A. Aviles, J. C. Diaz-Maqueo, A. Talavera, R. Guzman and E. L. Garcia, “Growth and Development of Children of Mothers Treated with Chemotherapy during Pregnancy: Current Status of 43 Children,” American Journal of Hematology, Vol. 36, No. 4, 1991, pp. 243-248. doi:10.1002/ajh.2830360404
 D. L. Berry, R. L. Theriault, F. A. Holmes, V. M. Parisi, D. J. Booser, S. E. Singletary, et al., “Management of Breast Cancer during Pregnancy Using a Standardized Protocol,” Journal of Clinical Oncology, Vol. 17, No. 3, 1999, pp. 855-861.
 D. A. Calhoun, C. Rosa and R. D. Christensen, “Transplacental Passage of Recombinant Human Granulocyte Colony-Stimulating Factor in Women with an Imminent Preterm Delivery,” American Journal of Obstetrics & Gynecology, Vol. 174, No. 4, 1996, pp. 1306-1311. doi:10.1016/S0002-9378(96)70676-2
 R. Fujiwaki, T. Hata, K. Hata, M. Kitao, H. Furuya and Y. Katoh, “Effective Treatment of Drug-Induced Agranulocytosis Using Recombinant Human Granulocyte Colony Stimulating Factor in Pregnancy,” Gynecologic and Obstetric Investigation, Vol. 40, No. 4, 1995, pp. 276-277. doi:10.1159/000292355
 H. A. Arango, C. S. Kalter, S. L. Decesare, J. V. Fiorica, G. H. Lyman and W. N. Spellacy, “Management of Chemotherapy in a Pregnancy Complicated by a Large Neuroblastoma,” Obstetrics & Gynecology, Vol. 84, No. 4, Part 2, 1994, pp. 665-668.
 S. J. Kaufmann, K. Sharif, V. Sharma and B. A. McVerry, “Term Delivery in a Woman with Severe Congenital Neutropenia, Treated with Growth Colony Stimulating Factor,” Human Reproduction, Vol. 13, No. 2, 1998, pp. 498-499. doi:10.1093/humrep/13.2.498
 T. Abe, H. Azuma, A. Watanabe, T. Shigekiyo, S. Endou, R. Pou, R. Fukui, K. Maeda, T. Aono and T. Matsumoto, “A Patient with Cyclic Neutropenia Complicated by Severe Persistent Neutropenia Successfully Delivered a Healthy Baby,” Internal Medicine, Vol. 39, No. 8, 2000, pp. 663-666. doi:10.2169/internalmedicine.39.663
 M. R. Sangalli, M. Peek and A. McDonald, “Prophylactic Granulocyte Colony-Stimulating Factor Treatment for Acquired Chronic Severe Neutropenia in Pregnancy,” Australian and New Zealand Journal of Obstetrics and Gynaecology, Vol. 41, No. 4, 2001, p. 470.
 M. Kikkawa, S. Matsubara, M. Takatoku, T. Kuwata, A. Ohkuchi, A. Izumi, T. Watanabe, M. Suzuki, “Granulocyte-Colony Stimulating Factor for the Treatment of Ritodrine-Induced Neutropenia,” Journal of Obstetrics and Gynaecology Research, Vol. 34, No. 2, 2008, pp. 286-290. doi:10.1111/j.1447-0756.2008.00773.x
 D. M. Niedermeier, D. A. Frei-Lahr and P. D. Hall, “Treatment of Acute Myeloid Leukemia during the Second and Third Trimesters of Pregnancy,” Pharmacotherapy, Vol. 25, No. 8, 2005, pp. 1134-1140. doi:10.1592/phco.2005.25.8.1134
 T. Ohba, T. Yoshimura, M. Araki, J. Miyoshi, Y. Yonemura, K. Matsuura and H. Okamura, “Aplastic Anemia in Pregnancy: Treatment with Cyclosporine and Granulocyte-Colony Stimulating Factor,” Acta Obstetricia et Gynecologica Scandinavica, Vol. 78, No. 5, 1999, pp. 458-461.
 G. Leitner, H. Loidolt, H. T. Greinix, P. Hocker and M. Dettke, “Granulocyte Colony Stimulating Factor-Induced Allogenic Peripheral Stem Cell Donation during Early Pregnancy,” British Journal of Haematology, Vol. 115, No. 1, 2001, pp. 233-234.
 T. E. Cottle, C. J. Fier, J. Donadieu and S. E. Kinsey, “Risk and Benefit of Treatment of Severe Chronic Neutropenia with Granulocyte Colony-Stimulating Factor,” Seminars in Hematology, Vol. 39, No. 2, 2002, pp. 134-140. doi:10.1053/shem.2002.31914